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SUMMARY 
The effect of intravitreal triamcinolone acetonid on retinal 
expression of vascular endothelial growth factor in diabetic rats  
Purpose: In this study we investigated the effect of intravitreal triamcinolone 
acetonide (IVTA) in streptozotocin-induced diabetic rats on vascular endothelial growth factor  
(VEGF) expression inthe retina. 
Materials and Methods: Male wistar rats were included in the study. Diabetes 
was induced by intraperitoneal single injection of streptozotocin (50 mg/kg). Diabetes was 
comfirmed by measuring blood glucose level using blood samples obtained from the tail vein 
on the third and seventh days. The rats included in the study if the blood glucose level was 
higher than 250 mg/dl.  
Fifteen days after the injection of streptozotocin, a single dose of triamcinolone 
acetonide (320 µg/ 8 µl) was injected into the vitreous by using a Hamilton micro-injector (30 
gauge) and an equal volume of balanced salt solution into the fellow eyes . Rats were 
sacrificed four weeks after the injection of streptozotocin, and the eyes  were enucleated. The 
retina speciemens obtained from the enucleated eyes were examined with using anti-VEGF 
markers by immunohistochemistry. 
Results: Decreased VEGF expressions were found in retinal layers of rats which 
were injected TA compared with the control eyes. However, no statisticaly significant 
difference was found between TA injected and control eyes. 
Conclusion: In this study, these findings shows that intravitreal triamcinolone 
acetat adminastration could not change VEGF expression in diabetic rats . These results 
suggest that IVTA does not cause any changes in VEGF release in diabetic rats and (probably) 
may not inhibit angiogenesis. 
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